ArticleExperimental and therapeutic medicine2013

Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion.

Jinru Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.